295 related articles for article (PubMed ID: 7005505)
1. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
2. Role of circulating antibodies in the humoral leukocyte adherence inhibition response of lung and breast cancer patients.
Kotlar HK; Sanner T
Cancer Lett; 1980 Nov; 11(1):11-9. PubMed ID: 7013972
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
Grosser N; Thomson DM
Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
[TBL] [Abstract][Full Text] [Related]
4. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
[TBL] [Abstract][Full Text] [Related]
6. Early detection of breast cancer by leukocyte adherence inhibition assay.
Sanner T; Kotlar HK; Eker P; Brennhovd I; Host H; Jorgensen O
Cancer Detect Prev; 1983; 6(4-5):443-50. PubMed ID: 6360351
[TBL] [Abstract][Full Text] [Related]
7. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
8. Humoral leukocyte adherence inhibition (H-LAI) before and after surgery in human breast cancer.
Horváth M; Tóth L; Tóth J; Fekete B
Neoplasma; 1985; 32(5):623-7. PubMed ID: 3906415
[TBL] [Abstract][Full Text] [Related]
9. Immune responses in lung cancer patients measured by a modified leukocyte adherence inhibition test using serum.
Sanner T; Kotlar HK; Eker P
Cancer Lett; 1980 Feb; 8(4):283-90. PubMed ID: 6989487
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
11. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
De Carli HO; Restbergs V
Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
[TBL] [Abstract][Full Text] [Related]
15. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
Tsang PH; Holland JF; Bekesi JG
J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
[TBL] [Abstract][Full Text] [Related]
16. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
17. Blocking of the response by human T-lymphocytes to extracts of autologous cancer by monoclonal antibody to Class-I major histocompatibility complex gene products in the leukocyte adherence inhibition assay.
Shenouda G; Thomson DM
Cancer Res; 1984 Jul; 44(7):2762-8. PubMed ID: 6609766
[TBL] [Abstract][Full Text] [Related]
18. [Micromodification of the leukocyte adherence inhibition test for cancer patients].
Kharkevich DD; Tabagari DZ; Savinov AIu
Vopr Onkol; 1985; 31(7):17-21. PubMed ID: 3895734
[TBL] [Abstract][Full Text] [Related]
19. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
Shenouda G; Thomson DM; MacFarlane JK
Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
[TBL] [Abstract][Full Text] [Related]
20. Humoral leukocyte adherence inhibition (H-LAI) test in screening of high risk group for lung cancer.
Kubasova T; Bank J; Köteles GJ; Horváth M
Neoplasma; 1990; 37(2):173-8. PubMed ID: 2188164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]